Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank C Barone

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Journal of Hypertension|April 13, 2004
Eprosartan improves cardiac performance, reduces cardiac hypertrophy and mortality and downregulates myocardial monocyte chemoattractant protein-1 and inflammation in hypertensive heart diseaseThomas M Behr, Robert N Willette, Robert W Coatney, et al.
International Journal of Nanomedicine|March 14, 2019
Long-term biocompatibility of fluorescent diamonds-(NV)-Z~800 nm in rats: survival, morbidity, histopathology, particle distribution and excretion studies (part IV)Frank C Barone, Cezary Marcinkiewicz, Jie Li, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|March 25, 2010
Selective CETP inhibition and PPARalpha agonism increase HDL cholesterol and reduce LDL cholesterol in human ApoB100/human CETP transgenic miceMichael K Hansen, Matthew J McVey, Ray F White, et al.
Journal of Neuroscience Methods|January 5, 2002
Programmable microchip monitoring of post-stroke pyrexia: effects of aspirin and paracetamol on temperature and infarct size in the ratJeffrey J Legos, Arduino A Mangoni, Simon J Read, et al.
International Journal of Nanomedicine|October 2, 2018
Pilot study on biocompatibility of fluorescent nanodiamond-(NV)-Z~800 particles in rats: safety, pharmacokinetics, and bio-distribution (part III)Frank C Barone, Cezary Marcinkiewicz, Jie Li, et al.
Neuroreport|August 16, 2011
A novel calpain inhibitor for treatment of transient retinal ischemia in the ratJoel David, Aleksandr Melamud, Leo Kesner, et al.
Plos One|September 8, 2017
The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficitsJin Zhou, Jie Li, Daniel M Rosenbaum, et al.
Journal of Clinical Medicine|February 27, 2026
RNA-Based Biomarkers for Diagnostic Discrimination of Ischemic and Hemorrhagic Stroke: A Systematic ReviewJan Emmerich, Aditya Chanpura, Frank C Barone, et al.
Stroke|February 2, 2002
Inhibition of factor IX(a) is protective in a rat model of thromboembolic strokeJohn R Toomey, Richard E Valocik, Paul F Koster, et al.
European Journal of Pharmacology|July 11, 2002
The selective p38 inhibitor SB-239063 protects primary neurons from mild to moderate excitotoxic injuryJeffrey J Legos, BethAnn McLaughlin, Stephen D Skaper, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Journal of Hypertension|April 13, 2004
Eprosartan improves cardiac performance, reduces cardiac hypertrophy and mortality and downregulates myocardial monocyte chemoattractant protein-1 and inflammation in hypertensive heart diseaseThomas M Behr, Robert N Willette, Robert W Coatney, et al.
International Journal of Nanomedicine|March 14, 2019
Long-term biocompatibility of fluorescent diamonds-(NV)-Z~800 nm in rats: survival, morbidity, histopathology, particle distribution and excretion studies (part IV)Frank C Barone, Cezary Marcinkiewicz, Jie Li, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|March 25, 2010
Selective CETP inhibition and PPARalpha agonism increase HDL cholesterol and reduce LDL cholesterol in human ApoB100/human CETP transgenic miceMichael K Hansen, Matthew J McVey, Ray F White, et al.
Journal of Neuroscience Methods|January 5, 2002
Programmable microchip monitoring of post-stroke pyrexia: effects of aspirin and paracetamol on temperature and infarct size in the ratJeffrey J Legos, Arduino A Mangoni, Simon J Read, et al.
International Journal of Nanomedicine|October 2, 2018
Pilot study on biocompatibility of fluorescent nanodiamond-(NV)-Z~800 particles in rats: safety, pharmacokinetics, and bio-distribution (part III)Frank C Barone, Cezary Marcinkiewicz, Jie Li, et al.
Neuroreport|August 16, 2011
A novel calpain inhibitor for treatment of transient retinal ischemia in the ratJoel David, Aleksandr Melamud, Leo Kesner, et al.
Plos One|September 8, 2017
The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficitsJin Zhou, Jie Li, Daniel M Rosenbaum, et al.
Journal of Clinical Medicine|February 27, 2026
RNA-Based Biomarkers for Diagnostic Discrimination of Ischemic and Hemorrhagic Stroke: A Systematic ReviewJan Emmerich, Aditya Chanpura, Frank C Barone, et al.
Stroke|February 2, 2002
Inhibition of factor IX(a) is protective in a rat model of thromboembolic strokeJohn R Toomey, Richard E Valocik, Paul F Koster, et al.
European Journal of Pharmacology|July 11, 2002
The selective p38 inhibitor SB-239063 protects primary neurons from mild to moderate excitotoxic injuryJeffrey J Legos, BethAnn McLaughlin, Stephen D Skaper, et al.
Pageof 5